Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study

被引:31
|
作者
Barbeito, Sara [1 ]
Vega, Patricia [1 ]
Ruiz de Azua, Sonia [1 ,3 ]
Saenz, Margarita [1 ]
Martinez-Cengotitabengoa, Monica [1 ,2 ]
Gonzalez-Ortega, Itxaso [1 ,3 ]
Bermudez, Cristina [1 ]
Hernanz, Margarita [1 ]
Fernandez de Corres, Blanca [1 ]
Gonzalez-Pinto, Ana [1 ,3 ,4 ]
机构
[1] Univ Hosp Alava, Biomed Res Ctr Mental Hlth Net CIBERSAM, Vitoria, Spain
[2] UNED, Madrid, Spain
[3] Univ Basque Country, Leioa 48940, Bizkaia, Spain
[4] Hosp Santiago, CIBERSAM G10, Dept Psychiat, Vitoria, Spain
来源
BMC PSYCHIATRY | 2013年 / 13卷
关键词
Adherence; Cannabis; First psychotic episode; Involuntary admission; 1ST EPISODE SCHIZOPHRENIA; 2-YEAR FOLLOW-UP; RATING-SCALE; MEDICATION ADHERENCE; RISK-FACTORS; PREDICTORS; DISORDERS; IMPACT; NONADHERENCE; HOSPITALIZATION;
D O I
10.1186/1471-244X-13-326
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: This study aimed to examine factors associated with treatment adherence in first-episode psychosis (FEP) patients followed up over 8 years, especially involuntary first admission and stopping cannabis use. Methods: This prospective, longitudinal study of FEP patients collected data on symptoms, adherence, functioning, and substance use. Adherence to treatment was the main outcome variable and was categorized as 'good' or 'bad'. Cannabis use during follow-up was stratified as continued use, stopped use, and never used. Bivariate and logistic regression models identified factors significantly associated with adherence and changes in adherence over the 8-year follow-up period. Results: Of the 98 FEP patients analyzed at baseline, 57.1% had involuntary first admission, 74.4% bad adherence, and 52% cannabis use. Good adherence at baseline was associated with Global Assessment of Functioning score (p = 0.019), Hamilton Depression Rating Scale score (p = 0.017) and voluntary admission (p < 0.001). Adherence patterns over 8 years included: 43.4% patients always bad, 26.1% always good, 25% improved from bad to good. Among the improved adherence group, 95.7% had involuntary first admission and 38.9% stopped cannabis use. In the subgroup of patients with bad adherence at baseline, involuntary first admission and quitting cannabis use during follow up were associated with improved adherence. Conclusions: The long-term association between treatment adherence and type of first admission and cannabis use in FEP patients suggest targets for intervention to improve clinical outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study
    Sara Barbeito
    Patricia Vega
    Sonia Ruiz de Azúa
    Margarita Saenz
    Mónica Martinez-Cengotitabengoa
    Itxaso González-Ortega
    Cristina Bermudez
    Margarita Hernanz
    Blanca Fernández de Corres
    Ana González-Pinto
    BMC Psychiatry, 13
  • [2] Long-term drug adherence in first-episode psychosis: the role of cannabis use and involuntary admission
    Martinez-Cengotitabengoa, M.
    Barbeito, S.
    Gonzalez-Ortega, I.
    Garcia-Alocen, A.
    Gonzalez-Pinto, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S496 - S497
  • [3] Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
    Gonzalez-Pinto, Ana
    Alberich, Susana
    Barbeito, Sara
    Gutierrez, Miguel
    Vega, Patricia
    Ibanez, Berta
    Haidar, Mahmoud Karim
    Vieta, Eduard
    Arango, Celso
    SCHIZOPHRENIA BULLETIN, 2011, 37 (03) : 631 - 639
  • [4] Differences in PANSS score progression at first-episode psychosis in children and adolescents with cannabis use; A longitudinal prospective study
    Trabsa, A.
    Munoz-Samons, D.
    Pardo, M.
    De Dios, M.
    Sanagustin, D.
    Del Cacho, N.
    Vila-Badia, R.
    Butjosa, A.
    Kaplan, M.
    Usall, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S490 - S491
  • [5] NGF and BDNF as markers of long-term functionality in first-episode psychosis patients with/without cannabis consumption
    Martinez-Cengotitabengoa, M.
    Saenz, M.
    Fernandez, M.
    de Azua, S. Ruiz
    Ugarte, A.
    Vega, P.
    Bermudez, C.
    Garcia-Alocen, A.
    Gonzalez-Pinto, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S432 - S433
  • [6] Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study
    Ricci, V
    Ceci, F.
    Di Carlo, F.
    Lalli, A.
    Ciavoni, L.
    Mosca, A.
    Sepede, G.
    Salone, A.
    Quattrone, D.
    Fraticelli, S.
    Maina, G.
    Martinotti, G.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 229
  • [7] Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis
    Schoeler, Tabea
    Petros, Natalia
    Di Forti, Marta
    Klamerus, Ewa
    Foglia, Enrico
    Murray, Robin
    Bhattacharyya, Sagnik
    LANCET PSYCHIATRY, 2017, 4 (08): : 627 - 633
  • [8] Cannabis use disorder and age at onset of psychosis A study in first-episode patients
    Kupferschmid, Stephan
    Conus, Philippe
    Cotton, Sue M.
    Karow, Anne
    Schultze-Lutter, Frauke
    McGorry, Patrick D.
    Lambert, Martin
    Schimmelmann, Benno G.
    SWISS MEDICAL WEEKLY, 2011, 141 : 57S - 57S
  • [9] Cannabis use disorder and age at onset of psychosis - A study in first-episode patients
    Schimmelmann, Benno G.
    Conus, Philippe
    Cotton, Sue M.
    Kupferschmid, Stephan
    Karow, Anne
    Schultze-Lutter, Frauke
    McGorry, Patrick D.
    Lambert, Martin
    SCHIZOPHRENIA RESEARCH, 2011, 129 (01) : 52 - 56
  • [10] Cannabis use in first-episode psychosis: Incidence and short-term outcome
    Rolfe, TJ
    McGory, P
    Cocks, J
    Longley, T
    Plowright, D
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 313 - 314